patients with gallbladder disease history require careful consideration Thyroid C-cell tumors : Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies, though human relevance remains uncertain
*In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Standard 100-130 angstrom columns used for small peptides produce poor peak shape and resolution for tirzepatide
It does not increase adrenaline, cortisol, or any other wake-promoting neurotransmitter through its primary mechanism of action
The dose can be gradually increased up to a maximum of 15 mg weekly based on your needs and tolerance